IMAX Stock Analysis: Imax | NYSE
Entertainment | NYSE, USA | Market Cap: 2.787m USD | 12M Return: 64.6% | CA45245E1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 51.1M
EPS Trend: 82.7%
Qual. Beats: 1
Rev. Trend: 55.3%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
IMAX Corporation is a Canada-based entertainment technology company, founded in 1967 and headquartered in Mississauga, that operates a global large-format theatrical and content platform. The business is organized into two segments: Content Solutions (which includes IMAXs proprietary DMR film remastering technology, IMAX Enhanced for streaming, AI-driven video quality tools, and distribution of documentaries, live events, and interactive performances) and Technology Products and Services (which covers the sale and lease of IMAX theater systems, camera rentals, post-production services, and maintenance support for the global IMAX network). The company sells and leases its systems to a diverse customer base, including commercial cinemas, museums, zoos, aquariums, theme parks, tourist destinations, and private home theaters, and generates after-market revenue from parts, 3D glasses, and management services.
The company is listed on the NYSE under the ticker IMAX and is classified within the GICS Movies & Entertainment sub-industry, a sub-sector of Communication Services that includes film production, theatrical exhibition, and streaming content providers. IMAXs business model is largely asset-light: rather than owning most of the screens that show its content, it licenses its brand, technology, and remastered films to a third-party exhibitor network, earning revenue through a mix of system sales/leases, ongoing maintenance fees, and a share of box office receipts from IMAX-format releases.
- Greater China box office recovery lifts IMAX network revenue
- Hollywood blockbuster slate drives content solutions segment growth
- IMAX Enhanced streaming partnerships expand home entertainment revenue
| Net Income: 40.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 8.32 > 1.0 |
| NWC/Revenue: 84.40% < 20% (prev 87.59%; Δ -3.19% < -1%) |
| CFO/TA 0.14 > 3% & CFO 132.6m > Net Income 40.9m |
| Net Debt (122.7m) to EBITDA (134.2m): 0.91 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.6m) vs 12m ago 2.55% < -2% |
| Gross Margin: 59.14% > 18% (prev 56.46%; Δ 2.68% > 0.5%) |
| Asset Turnover: 46.58% > 50% (prev 41.73%; Δ 4.85% > 0%) |
| Interest Coverage Ratio: 9.56 > 6 (EBIT TTM 71.6m / Interest Expense TTM 7.49m) |
| A: 0.38 (Total Current Assets 562.3m - Total Current Liabilities 211.1m) / Total Assets 917.9m |
| B: -0.25 (Retained Earnings -230.8m / Total Assets 917.9m) |
| C: 0.08 (EBIT TTM 71.6m / Avg Total Assets 893.2m) |
| D: 0.76 (Book Value of Equity 355.9m / Total Liabilities 467.5m) |
| Altman-Z'' = 3.03 = A |
| DSRI: 0.87 (Receivables 330.4m/331.3m, Revenue 416.1m/362.5m) |
| GMI: 0.95 (GM 56.46% / 59.14%) |
| AQI: 0.82 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.15 (Revenue 416.1m / 362.5m) |
| TATA: -0.10 (NI 40.9m - CFO 132.6m) / TA 917.9m) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of October 26, 2026, the stock is trading at USD 53.38 with a total of 930,148 shares traded. Over the past week, the price has changed by +5.04%, over one month by +0.15%, over three months by +21.43% and over the past year by +64.55%.
Current recommended Stop Loss: 48.90 (which is 8.4% or 2.6 ATR below the current price).
Imax has received a consensus analysts rating of 4.42. Therefore, it is recommended to buy IMAX.
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 58.3 | 9.3% |
P/E Trailing = 70.5833
P/E Forward = 28.9855
P/S = 6.6984
P/B = 8.2582
P/EG = 0.8895
Revenue TTM = 416.1m USD
EBIT TTM = 71.6m USD
EBITDA TTM = 134.2m USD
Long Term Debt = 243.8m USD (from longTermDebt, last quarter)
Short Term Debt = 38.8m USD (from shortTermDebt, last quarter)
Debt = 282.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 122.7m USD (calculated: Debt 282.6m - CCE 159.9m)
Enterprise Value = 2.91b USD (2.79b + Debt 282.6m - CCE 159.9m)
Interest Coverage Ratio = 9.56 (Ebit TTM 71.6m / Interest Expense TTM 7.49m)
EV/FCF = 23.02x (Enterprise Value 2.91b / FCF TTM 126.4m)
FCF Yield = 4.34% (FCF TTM 126.4m / Enterprise Value 2.91b)
FCF Margin = 30.38% (FCF TTM 126.4m / Revenue TTM 416.1m)
Net Margin = 9.84% (Net Income TTM 40.9m / Revenue TTM 416.1m)
Gross Margin = 59.14% ((Revenue TTM 416.1m - Cost of Revenue TTM 170.0m) / Revenue TTM)
Gross Margin QoQ = 61.16% (prev 56.29%)
Tobins Q-Ratio = 3.17 (Enterprise Value 2.91b / Total Assets 917.9m)
Interest Expense / Debt = 2.65% (Interest Expense 7.49m / Debt 282.6m)
Taxrate = 24.40% (15.2m / 62.3m)
NOPAT = 54.1m (EBIT 71.6m * (1 - 24.40%))
Current Ratio = 2.66 (Total Current Assets 562.3m / Total Current Liabilities 211.1m)
Debt / Equity = 0.79 (Debt 282.6m / totalStockholderEquity, last quarter 355.9m)
Debt / EBITDA = 0.91 (Net Debt 122.7m / EBITDA 134.2m)
Debt / FCF = 0.97 (Net Debt 122.7m / FCF TTM 126.4m)
Total Stockholder Equity = 344.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.58% (Net Income 40.9m / Total Assets 917.9m)
RoE = 11.87% (Net Income TTM 40.9m / Total Stockholder Equity 344.7m)
RoCE = 12.17% (EBIT 71.6m / Capital Employed (Equity 344.7m + L.T.Debt 243.8m))
RoIC = 7.47% (NOPAT 54.1m / Invested Capital 724.8m)
WACC = 6.29% (E(2.79b)/V(3.07b) * Re(6.73%) + D(282.6m)/V(3.07b) * Rd(2.65%) * (1-Tc(0.24)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.88 | Cagr: 2.59%
[DCF] Terminal Value 77.97% ; FCFF base≈94.8m ; Y1≈108.6m ; Y5≈159.9m
[DCF] Fair Price = 41.64 (EV 2.41b - Net Debt 122.7m = Equity 2.28b / Shares 54.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 82.74 | EPS CAGR: 21.96% | SUE: 2.28 | # QB: 1
Revenue Correlation: 55.32 | Revenue CAGR: 3.86% | SUE: 1.31 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.92 | Chg30d=+44.64% | Revisions=+50% | Analysts=9
EPS current Year (2026-12-31): EPS=2.13 | Chg30d=+11.42% | Revisions=+50% | GrowthEPS=+47.2% | GrowthRev=+16.0%
EPS next Year (2027-12-31): EPS=2.23 | Chg30d=+6.07% | Revisions=+50% | GrowthEPS=+4.4% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: +75% (up=9, down=0)